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Abstract
Manipulation of host phosphoinositide lipids has emerged as a key survival 
strategy utilized by pathogenic bacteria to establish and maintain a replication-per-
missive compartment within eukaryotic host cells. The human pathogen, Legionella 
pneumophila, infects and proliferates within the lung’s innate immune cells causing 
severe pneumonia termed Legionnaires’ disease. This pathogen has evolved strate-
gies to manipulate specific host components to construct its intracellular niche 
termed the Legionella-containing vacuole (LCV). Paramount to LCV biogenesis 
and maintenance is the spatiotemporal regulation of phosphoinositides, important 
eukaryotic lipids involved in cell signaling and membrane trafficking. Through a 
specialized secretion system, L. pneumophila translocates multiple proteins that 
target phosphoinositides in order to escape endolysosomal degradation. By specifi-
cally binding phosphoinositides, these proteins can anchor to the cytosolic surface 
of the LCV or onto specific host membrane compartments, to ultimately stimulate 
or inhibit encounters with host organelles. Here, we describe the bacterial proteins 
involved in binding and/or altering host phosphoinositide dynamics to support 
intracellular survival of L. pneumophila.
Keywords: bacteria, infection, effector proteins, pneumonia,  
Legionella pneumophila, phosphoinositides, host-pathogen interactions,  
membrane traffic
1. Introduction
Bacterial pathogens have evolved diverse and effective strategies to promote 
their survival in human cells. Some bacteria can circumvent the innate immune 
response, managing to replicate within macrophages, which are the first line of 
defense against microbial pathogens and genetically programmed to eradicate 
foreign particles. Mechanisms that bacteria employ to survive in macrophages 
include (i) acclimating to the acidic environment within the host lysosome, (ii) 
escaping the phagosome to persist inside the host cell cytoplasm, and (iii) eluding 
the endolysosomal pathway by establishing a replication permissive vacuole within 
the host [1]. The Gram-negative facultative intracellular bacterium, Legionella 
pneumophila, has adopted a survival strategy that relies on the establishment of 
a protective vacuole that avoids encounters with the endolysosomal pathway. By 
phagocytosis, macrophages internalize L. pneumophila into a membrane-bound 
compartment termed as phagosome. Upon uptake, L. pneumophila directs 
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membrane remodeling of the phagosomal compartment, employing a sizeable 
artillery of bacterial proteins that subvert multiple host cellular processes without 
compromising survival of the host cell throughout infection [2–4]. A specialized 
secretion system is responsible for translocating these proteins, known as effector 
proteins, from the bacterial milieu into the host cytosol [5–7]. Effector proteins do 
not share extensive homology with each other and are often composed of multiple 
domains that are functionally distinct [8, 9]. An emerging feature among effec-
tor proteins is their ability to recognize and bind host phosphoinositides (PIPs) 
[10], which are a series of phospholipids that play critical roles in coordinating cell 
signaling and membrane trafficking events in eukaryotic cells [11]. L. pneumophila 
effector proteins exploit the spatiotemporal regulation of host PIPs to facilitate the 
formation of the Legionella-containing vacuole (LCV) and to avoid the endolyso-
somal pathway. Disruption of the PIP distribution on the LCV membranes leads to 
bacterial degradation, illustrating that controlling PIP dynamics on and around the 
LCV is crucial for intracellular survival of L. pneumophila [12]. Here we will discuss 
the L. pneumophila effector proteins that contribute to vacuole biogenesis and 
maintenance through the exploitation of host phosphoinositides.
2.  Legionella pneumophila replicates in protozoan and innate  
immune cells
L. pneumophila is ubiquitously found in aquatic environments forming close 
associations with protozoans and often found as an intracellular parasite of free-
living amoeba [13]. In the human lung, L. pneumophila infects resident alveolar 
macrophages leading to severe pneumonia, known as Legionnaires’ disease, which 
can be fatal in immunocompromised individuals [14]. Outbreaks stem from 
contaminated water systems such as those supplying water towers, cooling systems, 
and decorative fountains [15]. In 2017, a study by the Centers for Disease Control 
and Prevention (CDC) found that L. pneumophila was the leading bacterial agent 
responsible for public drinking water-associated outbreaks within the United States 
[14]. The number of reported Legionnaires’ disease cases has been escalating since 
2000, presumably due to an increase in urbanization, reliance on industrial water 
systems, as well as improved diagnostic methods [16]. Legionella spp. can exist 
within biofilms or amoebal hosts in freshwater systems, transitioning between a 
replicative and a transmissive/virulent phase life cycle [17, 18]. Nutrient deprivation 
within a biofilm or host triggers the upregulation of genes encoding virulence traits 
such as motility, osmotic stress resistance, pigmentation production, and multiple 
virulence factors [17]. This change in gene expression primes the bacterium to be 
engulfed by a new host cell and tap into their nutrient resources.
Inter-kingdom horizontal gene transfer events and circulating mobile genetic 
elements over long-term coevolution with multiple hosts have extensively reshaped 
the plasticity of the Legionella spp. genomes [19]. All Legionella spp. contain a 
highly conserved type IV secretion system (T4SS), yet there are differences in the 
combination of effectors present in each species. An analysis of 38 Legionella spp. 
genomes revealed that DNA exchange between species is rare and only seven core 
effectors are shared by all sequenced species [8]. Legionella effectors share more 
similarity with eukaryotic proteins than prokaryotic proteins, suggesting Legionella 
spp. have acquired their effector arrays from their hosts [20]. A striking number of 
effectors across the genus (>18,000) contain eukaryotic-derived domains [9]. This 
extensive combination of effectors likely stems from intimate coevolution between 
Legionella spp. with diverse protozoan hosts, such as Acanthamoeba castellanii [13], 
Hartmannella vermiformis [21], Dictyostelium discoideum [22, 23], Tetrahymena 
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pyriformis [24], and Naegleria fowleri [25]. Only 20 of the 65 known species have 
been associated with human disease, suggesting that perhaps Legionella species are 
better adapted for infection within their amoebal hosts [9]. A clear set of effectors 
that render Legionella better suited for human infection is not apparent, although 
conservation of ankyrin motifs, F-box, or Set18 domains was predominantly found 
in more virulent strains [9].
The prevailing thought is that the mechanisms that enable L. pneumophila to 
infect and proliferate within protozoa have equipped this bacterium with the ability 
to survive within innate immune cells. This ability could be due to the high con-
servation of the pathways involved in uptake and microbial degradation between 
protozoa and human macrophages. In the lung, resident macrophages and neu-
trophils engulf L. pneumophila by phagocytosis but are often unable to degrade it 
through phagosome maturation [26–28], a process that entails sequential fusion of 
the phagosome with endocytic compartments and ultimately the lysosome [29]. L. 
pneumophila is initially encased within a phagosome after macrophage engulfment, 
but within minutes, the membrane of this phagosome is drastically remodeled into 
a compartment resembling the endoplasmic reticulum (ER) [2, 4]. Tubular ER and 
secretory vesicles are rapidly routed toward the phagosome where some eventually 
fuse with the phagosomal membrane, allowing the phagosome to adopt the identity 
of the recruited host membrane [30]. While promoting LCV membrane fusion with 
the ER and Golgi-derived vesicles, L. pneumophila prevents fusion with endosomal 
compartments. Studies have found that L. pneumophila effector proteins can target 
specific host membrane compartments, including early endosomes, recycling endo-
somes, and autophagosomes. Collectively, these effectors help L. pneumophila evade 
the macrophage’s pre-programmed lysosomal degradation pathway [10], although 
precisely how these events are choreographed is not well understood.
The extensive remodeling of the vacuolar membrane is entirely dependent on 
a specialized Dot/Icm T4SS that delivers a staggering number of bacterial effec-
tor proteins (over 350) [8] into the host cytosol, many of which target membrane 
transport pathways [31, 32]. Disruption of the T4SS results in lysosomal degrada-
tion of the bacterium, indicating that the actions of effector proteins are paramount 
to bacterial survival [33]. However, it is often a challenge to identify an observable 
phenotype that can be attributed to a single effector because of functional redun-
dancy among bacterial effectors [34]. Many advances have been made to dissect 
the molecular contribution of individual effectors toward bacterial infection 
(reviewed in [35]). A number of these effectors have been reported to hijack host 
vesicular trafficking pathways. An emerging feature among some of the effectors 
that target membrane trafficking is the ability to bind key host regulatory lipids, 
phosphoinositides (PIPs).
3. Phosphoinositides as crucial regulators of vesicular trafficking
Membrane compartments within eukaryotic cells are highly abundant, dynamic, 
and functionally distinct structures. Their movement must be tightly regulated 
to ensure that cargo carried by these structures is delivered to the proper destina-
tion. The cellular machinery recognizes and distinguishes these compartments 
based on the unique protein and lipid composition on the cytosolic leaflet of the 
membrane lipid bilayer [11]. Phosphoinositides are glycerophospholipids that 
amount to less than 15% of phospholipids within membranes but are essential for 
coordinating the spatiotemporal regulation of membrane trafficking events [11]. 
Phosphatidylinositol (PI), the precursor of phosphoinositides, can be reversibly 
phosphorylated at positions 3, 4, and 5 of its myo-inositol ring resulting in the 
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generation of seven PIP species [11]. Membrane compartments are characterized in 
part by the presence of distinct PIP species that essentially act as molecular anchors 
to facilitate protein recruitment and attachment to specific compartments [11]. PI 
is synthesized in the endoplasmic reticulum and delivered to membrane-bound 
compartments via vesicular transport or cytosolic PI transfer proteins [11]. The 
Golgi and plasma membrane are highly enriched with PI(4)P, while lower levels 
of PI(4)P are also found within membranes of the ER and late endosomes [11, 36, 
37]. PI(3)P is mainly found on phagosomes, early endosomes, late endosomes, and 
multivesicular bodies (MVBs). MVBs and late endosomes also contain PI(3,5)P2, 
which is the dominant PIP on lysosomes. Phagocytosis and phagosome maturation 
are entirely dependent on phosphoinositide dynamics [38]. PI(4,5)P2 and PI(3,4,5)
P3 are present on the plasma membrane and are critical for recruiting the cellular 
machinery for initiating phagocytosis. Once phagosomes have been formed, PI(3)P 
is the predominant PIP on the organelle [29]. PI(3)P then triggers the recruitment of 
proteins to the phagosome, such as EEA1 and its subsequent effector Rab5, to facili-
tate docking and fusion with early endosomes and progression down the phagolyso-
somal maturation pathway [39]. Blocking the formation of these PIP species results 
in robust inhibition of phagocytosis [40]. Given the crucial importance of PIPs for 
particle uptake and degradation, it is not surprising that intracellular bacteria have 
evolved molecular mechanisms to take command of these eukaryotic lipids.
4. Phosphoinositide dynamics on the LCV
The PIP composition on the LCV membrane has profound effects on the fate of 
the bacteria-bearing vacuole. PI conversion that accompanies LCV maturation was 
deciphered by tracking the localization of fluorescent PI probes produced in the soil 
amoeba, Dictyostelium discoideum, which serves as a model organism for the study 
of host-pathogen interactions [41]. As L. pneumophila enters D. discoideum, the 
phagocytic cup is coated with PI(3,4,5)P3. On the membrane of the newly formed 
phagosome, PI(3,4,5)P3, PI(3,4)P2, and PI(4)P persist for less than 60 s on average. 
By 60 s, the phagosome begins to accumulate PI(3)P. Over the next 2 h, PI(4)P lev-
els increase, the LCV lumen expands, and PI(3)P is slowly lost and excluded from 
the maturing LCV. The mature LCV maintains a discrete pool of PI(4)P separate 
from the surrounding ER, in which it acquires 30 to 60 min after uptake. As the 
bacterium continues to replicate, PI(4)P levels are steadily maintained on the LCV 
but are present in pools distinct from the surrounding ER network. The conversion 
from a PI(3)P to a PI(4)P-positive compartment is secretion system-dependent: 
a mutant strain lacking a functional T4SS accumulates PI(3)P on the LCV, PI(4)
P is never acquired, and the LCV is destined for lysosomal degradation [12]. Thus, 
translocated effectors control the PIP composition of the LCV and potentially other 
host membranes.
In a recent study, Weber and colleagues [42] pursued the source of the PI(4)
P on the LCV membrane. Real-time high-resolution confocal laser scanning 
microscopy (CLSM) revealed that LCVs of infected D. discoideum capture PI(4)P 
from trans-Golgi-derived vesicles. PI(4)P-enriched vesicles accumulate close to the 
LCV, even in the absence of the T4SS, but retention of these vesicles relies on the 
T4SS. This observation indicates that while PI(4)P-positive compartments localize 
to phagosomes regardless of the internalized cargo, effector proteins are needed to 
prolong this interaction. The removal of PI(3)P from the phagosome membrane 
was thought to occur through the actions of PIP-modifying enzymes; however, 
CSLM imaging of infected D. discoideum revealed shedding of PI(3)P-positive 
vesicles from the LCV. Moreover, the timing of PI(3)P shedding coincided with the 
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gradual accumulation of PI(4)P-compartments around the LCV [42]. Together, these 
observations support the notion that L. pneumophila adopts a combined strategy to 
convert the LCV from a PI(3)P- to PI(4)P-enriched compartment, employing both 
direct modification of PIPs on the LCV membrane and selective association with 
host vesicles.
5.  L. pneumophila effector proteins alter the PIP composition of  
the LCV membrane
To manipulate the PIP composition on the LCV, L. pneumophila uses both 
genetically encoded and host-derived PI kinases and phosphatases (Figure 1). 
Converting the PI(3)P-enriched phagosome to a predominantly PI(4)P-positive 
compartment requires a concerted effort between enzymes that add and remove 
Figure 1. 
L. pneumophila converts the phagosome to a PI(4)P-rich vacuole. Within a minute of uptake into the 
host cell, the LCV acquires the endosomal phosphoinositide, PI(3)P. Within an hour of infection, the LCV 
starts to accumulate PI(4)P until the bacteria are completely encapsulated in a PI(4)P-rich membrane. 
To avoid progression down the phagosome maturation pathway, L. pneumophila translocates effectors that 
alter the phosphoinositide composition on the LCV membrane to a PI(4)P-positive compartment (inset). 
This process is a result of close association and fusion with host vesicles as well as the direct conversion of 
existing phosphoinositides by kinases and phosphatases. Golgi-derived PI(4)P-positive vesicles accumulate 
around the LCV and later fuse with the vacuolar membrane. In contrast, PI(3)P-containing vesicles 
traffic toward the LCV but do not fuse with it. Additionally, the Legionella effector LepB is a PI kinase 
that phosphorylates PI(3)P and generates PI(3,4)P2 on the LCV membrane. This PI is a substrate for 
SidF which dephosphorylates PI(3,4)P2 to PI(4)P. While the origin of PI(3)P that LepB utilizes as a 
substrate is undetermined, LegA5 is a PI 3-kinase produced by Legionella that phosphorylates PI and could 
lead to additional PI(3)P on the LCV for conversion to PI(4)P. In combination, LegA5, LepB, and SidF 
may provide a cascade of enzymatic events for converting the LCV into a PI(4)P-positive compartment. 
SidP, another direct modifier of phosphoinositides produced by Legionella, may also contribute to the 
avoidance of the endocytic pathway by removing the phosphate from PI(3)P to hinder vesicle fusion. VipD 
localizes to endosomes and hydrolyzes a lipid tail from PI(3)P to potentially limit their interaction with 
the LCV. During this phosphoinositide conversion, Legionella effectors associate with the LCV through 
phosphoinositide binding domains. Some effectors localize by binding PI(3)P (RavD, LidA, SetA, LpnE, 
RidL, LtpD, LtpM), and some can associate via PI(4)P-binding (LidA, Lem4, SidM, SidC, Lem28, 
SdcA). During the later stages of infection, PI(3)P is undetectable and PI(4)P has become enriched on the 
expanding vacuole.
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a phosphate group of the myo-inositol head group. The direct PI 4-kinase activity 
of the effector LepB could potentially initiate the conversion process to a PI(4)
P-positive membrane by converting PI(3)P to PI(3,4)P2. LepB was initially identi-
fied as an effector that is involved in bacterial egress [43]. Since then, LepB was 
found to localize to the LCV, where it contributes to the dynamics of Rab1 by acting 
as a GTPase-activating protein (GAP) [44, 45]. Found between amino acids 313 and 
618, the structure and mechanism of the GAP domain is now well understood [46–
48]. The N-terminal domain consisting of the first 311 amino acids garnered inter-
est as this domain alone could disrupt the structure and function of the Golgi. The 
crystal structure of LepB1–618 revealed homology to atypical kinases such as CtkA 
from Helicobacter pylori and actin-fragmin kinase from Physarum polycephalum. 
When mutating residues capable of performing phosphorylation, the yeast toxicity 
phenotype was found to be suppressed. While this suggested a kinase functionality, 
the pocket for a substrate was too small to accommodate proteins any larger than 
Rab GTPases. However, LepB did not phosphorylate any of the tested Rab GTPases. 
Instead, the LepB substrates were revealed to be phosphoinositides. Studies showed 
that LepB, but not the catalytically inactive mutant LepBH154A, caused the sensor for 
PI(3,4)P2 and PI(3,4,5)P3 to relocate from a cytosolic to punctate distribution, while 
the signal for PI(3)P diminished dramatically. Ultimately, an in vitro kinase assay 
validated that LepB is a PI 4-kinase with specificity for PI(3)P and a level of activity 
comparable to the host kinase PI4KIII. By phosphorylating PI(3)P on the LCV, LepB 
could be initiating the vacuole’s phosphoinositide conversion to PI(4)P by providing 
the PI(3,4)P2 intermediate step [49].
As PI(3,4)P2 is generated on the LCV, it is thought that SidF can dephosphory-
late this lipid to PI(4)P. SidF is a membrane protein containing a large N-terminal 
domain followed by two transmembrane domains triggering localization to the 
LCV. SidF was the first L. pneumophila effector found to directly modify phos-
phoinositides through a screen for the well-known CX5R phosphatase motif in the 
effector repertoire. SidF is a PI 3-phosphatase: this effector hydrolyzes the phosphate 
group at the third position of PI(3,4)P2 or PI(3,4,5)P3 to produce PI(4)P or PI(4,5)
P2, respectively; however, it displays a preference for PI(3,4)P2. The mutation of 
the catalytic cysteine at residue 645 to a serine resulted in the abrogation of this 
phosphatase activity. As described in the following sections, PI(4)P on the LCV 
membrane can serve as a means for effectors, such as SidC, to anchor onto the 
LCV. Infection with a mutant lacking sidF shows significantly fewer vacuoles positive 
for SidC, suggesting that SidF contributes to the generation of PI(4)P on the LCV.
Ultimately, the functions of LepB and SidF suggest that PI(3)P can be converted 
to PI(4)P through the sequential efforts of these enzymes. The deletion of lepB 
and sidF individually shows a significant deficiency of SidC on the LCV membrane 
at similar levels [49, 50]. The deletion of both effectors simultaneously causes a 
decrease in SidC acquisition on the membrane no greater than the single-mutant 
strains, suggesting that these effectors are functioning in a linear pathway [49]. 
However, the complete loss of SidC was not seen in the infection with a lepB sidF 
double-deletion mutant. Additionally, both lepB and sidF are not always found in 
other Legionella species. Together, this suggests that there are other Legionella effec-
tors or host proteins manipulating the LCV PIP landscape.
The screen that identified SidF as a PI phosphatase also yielded SidP as another 
direct modifier of phosphoinositides. SidP was identified as a candidate due to 
its CX5R motif. It was found to have PI 3-phosphatase activity, cleaving PI(3)
P and PI(3,5)P2 in vitro. The L. longbeachae orthologue of SidP was only found 
to hydrolyze PI(3)P, suggesting this lipid may be the true target. SidP was also 
found to act as a PI 3-phosphatase in vivo when it suppressed yeast toxicity in a PI 
3-phosphatase-deficient mutant but not a mutant lacking PI 4-phosphatases. This 
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activity was confirmed when the levels of PI(3)P, but not PI(4)P or PI(4,5)P2, were 
decreased in the presence of SidP [51]. Nonetheless, the purpose of SidP’s phospha-
tase activity for successful infection has not yet been determined. We can speculate 
that SidP may work alongside LepB to quickly eliminate PI(3)P from the vacuole. As 
LepB converts PI(3)P to PI(3,4)P2, SidP may be dephosphorylating PI(3)P to PI to 
completely deplete the membrane of this phospholipid that would otherwise trigger 
the phagocytic maturation.
As part of an effort to determine the function of a Francisella effector, OpiA, 
LegA5 was found to possess PI 3-kinase activity. LegA5 contains two motifs, 
DXHXXN and IDH, separated by 14 amino acids that are characteristic of the cata-
lytic and activation loops of PI 3-kinases (and PI 4-kinases) [52]. PI(3)P has been 
shown to accumulate on the LCV early during infection in a manner independent of 
effector protein translocation [12]. This lipid is speculated to be the substrate LepB 
that acts on to initiate the PI(3)P to PI(4)P conversion on the phagosome mem-
brane. However, Legionella may encode an effector that also contributes to the PI(3)
P pool. These proteins may be delivered to the LCV in a complex so that PI is effi-
ciently converted to PI(4)P. Alternatively, or perhaps in addition, PI(3)P-positive 
vesicles that accumulate around the nascent Legionella-containing phagosome may 
serve as a source for the initial wave of PI(3)P.
Aside from kinases and phosphatases that change the phosphorylation state 
of PIPs, Legionella also encodes 19 phospholipases. Phospholipases differ from 
PI phosphatases by cleaving the phospholipid backbone instead of hydrolyzing a 
phosphate on the myo-inositol head group. While these proteins can enter the host 
through different systems such as the Sec, Tat, T2SS, T4SS, and outer membrane 
vesicles (OMVs), only phospholipases translocated via T4SS will be discussed here 
[53]. The best characterized T4SS-secreted phospholipase is VipD. VipD has three 
paralogs, VpdA, VpdB, and VpdC, which are also T4SS substrates but have yet to 
be studied in detail [54]. The structure of VipD shows two distinct domains: the 
N-terminal domain has phospholipase activity A, indicating cleavage of the ester 
bond releasing a fatty acid chain, and the C-terminal domain causes localization 
to early endosomes and interacts directly with Rab5 and Rab22 [55]. The phospho-
lipase activity is activated when VipD is bound to Rab5 due to a conformational 
change that exposes the active site [56, 57]. The activation of VipD causes cleavage 
of PI(3)P on endosomal membranes that prevents normal localization of membrane 
trafficking regulators, contributing to endosomal avoidance by Legionella [56].
While VipD has phospholipase A activity, Legionella also translocates two T4SS 
effectors with phospholipase C and D activity. A phospholipase C hydrolyzes the 
phosphorus-oxygen bond, releasing the phosphate of the phospholipid and the 
attached head group, and a phospholipase D solely cleaves off the attached head 
group. The phospholipase C effector protein, PlcC, is able to cleave phospholipids 
such as phosphatidylglycerol, phosphatidylcholine, and phosphatidylinositol [58]. 
Alone or in combination with two other phospholipase C effectors, PlcA and PlcB, 
translocated by the T2SS, these effectors were dispensable for growth in amoeba 
and macrophages. However, a triple mutant of these phospholipases displayed inef-
ficient killing of larvae in the G. mellonella infection model compared to the wild 
type [58]. It is not yet known how this function may contribute to intracellular sur-
vival. We speculate that perhaps removing the head group on these phospholipids, 
specifically PI, would render them incapable of being modified by PI kinases and 
phosphatase and prevent the vacuole from being quickly converted to an endosome-
like membrane. It would be interesting to determine if this phospholipase activity 
alters the PI composition of the LCV.
Lastly, the phospholipase D effector, LpdA, was first identified due to its homol-
ogy with known phospholipase D enzymes [59]. LpdA specifically cleaves the head 
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group from PI, PI(3)P, PI(4)P, and phosphatidylglycerol in vitro [60]. While LpdA 
localizes to the LCV [59], it is not known if or how this effector contributes to phos-
phoinositide dynamics. Nonetheless, deleting this gene results in the attenuation of 
growth in a mouse model [60].
LppA is a phytase enzyme that dephosphorylates the compound myo-inositol 
hexakisphosphate, known as phytate. While LppA’s phosphatase activity on phytate 
may play various roles during infection, of interest to this review are its effects on 
phosphoinositides. The inositol phosphate head group of PIPs is similar in structure 
to phytate. LppA was shown to dephosphorylate PI(3,4)P2 and PI(4,5)P2 as well as, 
but less efficiently, PI(3,4,5)P3 to PI(4)P in vitro. However, infection with an lppA 
deletion strain did not impact the presence of PI(4)P on the LCV [61]. It is possible 
that lack of LppA generates a more subtle phenotype that requires more sensitive 
detection methods.
In addition to directly manipulating the phosphoinositide composition of the 
vacuolar membrane, Legionella may change the PIP landscape by enlisting host 
enzymes. For instance, the host PI 5-phosphatase OCRL1 is recruited to the LCV in a 
T4SS-dependent manner. OCRL1 preferentially removes a phosphate from PI(4,5)P2 
to generate PI(4)P [62]. The homolog of OCRL1 in Dictyostelium, Dd5P4, was found 
to localize to LCVs where it is catalytically active and therefore able to dephosphory-
late PIPs [63]. How OCRL1 is recruited to the LCV is not yet clear, but it is thought 
that Legionella protein LpnE may contribute to this process. LpnE is a Sel1-like repeat 
protein translocated into host cells in a T4SS-independent manner, and it seems to be 
exported extracellularly through an unknown mechanism [64]. LpnE is important 
for entry into amoebae and macrophages as well as intracellular replication. In vitro 
LpnE binds PI(3)P and interacts with OCRL1, but it does not seem to be essential for 
recruitment of OCRL1 to the LCV. It may be that LpnE synergizes with other effec-
tors to stably recruit OCRL1, but this idea remains to be tested [63].
6. L. pneumophila effector proteins specifically bind phosphoinositides
Central to the ability of L. pneumophila to grow within both mammalian and 
protozoan cells is the remodeling of the phagosomal membrane through the 
manipulation of host secretory and endosomal trafficking. The loss of PI(3)P and 
the acquisition of PI(4)P on the phagosome membrane are achieved through a 
concerted mechanism carried out by the actions of multiple effector proteins. The 
acquisition of PI(4)P on the phagosome membrane is imperative for the subsequent 
recruitment of membranes to promote vacuole expansion [12]. PI(4)P on the LCV 
can serve as a docking site for effector attachment to ensure effectors are directed to 
the correct compartment within the cell [65]. Many effectors that bind to PI(4)P on 
the LCV are involved in the recruitment and fusion of secretory vesicles and ER. In 
addition to directly producing PI(4)P on the LCV via effector-driven phosphoryla-
tion and dephosphorylation of PIPs, it was recently reported that the phagosome also 
derives PI(4)P from the membrane material of secretory vesicles, demonstrating L. 
pneumophila employs multiple tactics to acquire PI(4)P. A number of PI(3)P-binding 
effectors have also been identified [66]. The few whose functions have been charac-
terized interfere with phagosomal maturation, retrograde trafficking, and autophagy 
[67–70]. An overview of L. pneumophila effectors that target PIPs is in Table 1.
6.1 L. pneumophila T4SS effectors that bind PI(4)P
Bacterial effectors translocated early during infection have been shown to 
facilitate the recruitment and fusion of ER/secretory vesicles with the LCV. SidM 
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(DrrA), an effector protein translocated immediately upon infection, localizes to 
the LCV and plays a crucial role in ER recruitment by exploiting the activity of 
Rab1, a small GTPase responsible for the transport of vesicles between the ER and 
Golgi [71–74]. SidM is a modular protein consisting of an N-terminal adenylyl-
transferase domain, a C-terminal PI(4)P-binding domain, and a central guanine 
nucleotide exchange factor (GEF) domain that activates the small GTPase Rab1 
by facilitating the exchange of GDP with GTP [73]. SidM’s adenylyltransferase 
activity covalently adds an adenosine monophosphate moiety onto Tyr 77 of Rab1, 
locking this small GTPase in its active conformation. Activated Rab1 is required 
for the recruitment of secretory vesicles to the LCV [73, 74]. SidM then promotes 
the tethering and fusion of these compartments with the phagosome membrane 
by interacting with an exocyst complex comprised of Sec5 and Sec15 [75]. A 
Table 1. 
Legionella pneumophila effectors targeting PI(3)P and PI(4)P.
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high-resolution crystal structure of SidM revealed a novel fold within the protein 
structure, termed P4M, that was responsible for binding PI(4)P with an unprec-
edented high affinity in the nanomolar range [76]. Two additional PI(4)P-binding 
effectors, Lem4 and Lem28, contain C-terminal domains similar to the P4M domain 
[77]. While Lem4 and Lem28 localize to the LCV through their PI(4)P-binding 
domains, they do not act on Rab1. Lem4 was recently demonstrated to be a phos-
photyrosine phosphatase [78], although how this enzymatic function contributes to 
infection has yet to be determined.
Multiple effectors manipulate Rab1 to exploit secretory trafficking [44, 79]. 
While SidM is required for activating this small GTPase on the LCV, the PI(3)P  
and PI(4)P binder, LidA, protects Rab1 from being inactivated [73, 74, 80]. LidA 
also localizes to the early LCV as well as other uncharacterized membrane com-
partments [73, 74, 80]. Unlike P4M-containing effectors, LidA interacts with PIPs 
through a central coiled-coil region. LidA interacts with AMPylated Rab1 through 
the same coiled-coil domain, preventing GAPs from accessing Rab1 to deactivate it. 
It is unknown whether the PIP interaction contributes to LidA’s function.
In addition to SidM, the PI(4)P binders SidC and its paralogue, SdcA, are also 
required for the recruitment of ER proteins to the LCV. In the absence of sidC, 
only 20% of LCVs acquire the ER marker calnexin, indicating that the interaction 
of LCVs with the ER is severely impaired upon deletion of this gene [81]. SidC 
and SdcA interact with PI(4)P using a 20 kDa C-terminal-binding domain (P4C) 
that does not share similarities with P4M or other eukaryotic PIP-binding motifs. 
Mutations that abolish P4C-PI(4)P interactions reduced ER recruitment to the LCV, 
indicating that SidC’s PI(4)P-binding activity is critical for remodeling the LCV 
membrane [82].
6.2 L. pneumophila T4SS effectors that bind PI(3)P
Multiple PI(3)P-binding effectors have been identified, and several were 
shown to be involved in preventing the LCV from entering the phagosomal matu-
ration pathway. AnkX binds both PI(3)P and PI(4)P in vitro, and in macrophages 
infected with a mutant strain lacking AnkX, the lysosomal marker, LAMP1, 
accumulates around the LCV indicating it is being routed for endolysosomal deg-
radation [70]. AnkX’s N-terminal FIC domain harbors phosphocholine transferase 
activity catalyzing, the covalent attachment of a phosphocholine moiety onto a 
serine or threonine residue of Rab1 and Rab35 [83, 84]. It is unknown whether 
AnkX localizes to the LCV, and despite its ability to covalently modify Rab1, it 
does not enhance retention of Rab1 on the LCV as observed for SidM-catalyzed 
adenylylation of Rab1. Phosphocholination locks Rab35 in an inactive confor-
mation by preventing interaction with its cognate GEF, connecdenn; however, 
phosphocholinated Rab1 was still able to interact with SidM, which also acts as 
a GEF [85]. AnkX disrupts endocytic recycling in infected macrophages in a 
phosphocholination-dependent manner, suggesting that phosphocholination of 
Rab35, a key regulator of endocytic recycling, may be responsible for this pheno-
type [86].
The PI(3)P-binding effector, RavD, also contributes to preventing encounters 
between lysosomes and the LCV. Transmission electron microscopy and structured-
illumination microscopy revealed RavD is present on the LCV membrane and vesicles 
adjacent to the LCV; however the identity of these vesicles has not yet been revealed. 
RavD binds PI(3)P via a C-terminal region [67]. A recent study reported that RavD’s 
N-terminal region harbors deubiquitinase activity (DUB) that specifically cleaves 
linear ubiquitin chains from the LCV using a Cys-His-Ser triad [87]. Deletion of ravD 
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causes the LCV to become decorated with linear ubiquitin and triggers subsequent 
activation of the NF-κB pathway [87]. Since Legionella species have not coevolved 
with macrophages, it is possible that RavD’s DUB activity would be functional in 
both macrophages and protozoan hosts. It would be interesting to determine RavD’s 
substrates in the context of a macrophage versus amoebae infection. Understanding 
the functional link between RavD’s DUB activity and its contribution to the prevention 
of LCV-endolysosomal fusion could provide novel insight into why pathogens exploit 
ubiquitin during infection.
L. pneumophila’s cohort of effectors includes multiple deubiquitinases that have 
evolved to act on different ubiquitin chains. Effector LotA localizes to the LCV 
through interaction with PI(3)P and harbors dual DUB activity to remove ubiquitin 
from the LCV [88]. LotA uses a C13 residue that acts against K6 linkages and a C303 
residue that acts against K48 and K63 linkages, although C303 has a more consider-
able contribution to removing ubiquitin from the LCV. A Legionella strain lacking 
LotA and the ubiquitin-associated SidE family of effectors resulted in impaired 
bacterial growth within murine bone marrow-derived macrophages, indicating 
LotA has coordinated activity with other L. pneumophila ubiquitin-modifying 
enzymes [88]. While it has not been reported whether the SidE effector family 
interacts with PIPs, it cannot be ruled out that these ubiquitin-modifying enzymes 
may also rely on PIPs to correctly direct them to the sites where their enzymatic 
activity is required.
The effector RidL binds PI(3)P and inhibits retrograde transport through 
molecular mimicry. Retrograde trafficking serves as a conduit that connects 
endosomes, the trans-Golgi network, and the ER [89]. Cargo that is cycled from 
endosomes to the Golgi is recognized and sorted by a retromer complex. Ectopically 
expressed RidL blocks retrograde trafficking at endosome exit sites through interac-
tions with the retromer complex protein, Vps29 [68]. RidL is present on the LCV 
membrane and endosomes but does not localize to endosomes through interactions 
with PI(3)P. Instead, RidL inserts itself into the endosomal retromer complex 
through interactions with Vps29, displacing Vps29 from binding to the Rab7 GAP, 
TBC1D5. RidL interacts with Vps29 using a hairpin loop that mimics the same 
manner in which TBC1D5 interacts with Vps29 [90]. This displacement blocks the 
movement of retrograde vesicles through an unknown mechanism. In the absence 
of ridL, LCVs accumulate lysosomal markers and retrograde cargo such as CI-MPR, 
which delivers acidic hydrolases to endocytic compartments [90]. This suggests the 
LCV may accept cargo or membranes from a subset of endosomal pathways and 
that RidL could intercept these incoming vesicles.
PI(3)P is also present on autophagosomes [91], and studies found that indeed 
L. pneumophila effectors also interfere with the dynamics of these compartments 
[69]. Autophagy is a conserved process across eukaryotic species that is triggered by 
cellular stress and serves as an additional defense mechanism against intracellular 
pathogens. Autophagy progression relies on a series of membrane reconstruction 
events, starting with phagophore membrane nucleation, to phagophore elonga-
tion and fusion to form the PI(3)P-rich autophagosome and ultimately fusion 
with lysosomes to degrade the internal cargo [91]. Early phagophore formation 
events are dependent on the presence of PI(3)P, which stimulates the recruitment 
of PI(3)P-binding proteins on ER-derived omegasomes [91]. Phagophore closure 
is completed through conjugation of LC3 to phosphoethanolamine (PE) on the 
phagophore membrane [92, 93]. Effector RavZ inhibits autophagy by extracting 
lipidated LC3 from autophagosome membranes and generating a modified LC3 
product that lacks the essential C-terminal glycine required for reconjugation back 
onto autophagosome membranes.
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RavZ localizes to autophagosome membranes through a C-terminal domain 
that recognizes PI(3)P. RavZ1–331 contains catalytic activity yet displays reduced 
LC3-PE extraction, indicating proper localization to phagosomes is needed 
to inhibit autophagy [94]. This high-affinity PI(3)P-binding domain, termed 
LED027, contains two conserved tyrosine and lysine residues that are key for 
PI(3)P binding. LED027 is found in two other effectors, Lpg1121 (Ceg19) and 
Lpg1961, although Lpg1961 did not display lipid-binding activity when tested 
in vitro [66]. It would be interesting to determine if these LED027-containing 
effectors also preferentially localize to PI(3)P on autophagosomes, possibly 
unveiling a novel conserved domain that confers autophagy-related activity in 
bacterial effectors.
While effectors rely on PIPs for proper localization, binding to PIPs can also 
induce the enzymatic activity of some effectors. Effector protein SetA possesses 
an N-terminal region with glucosyltransferase activity and a C-terminal PI(3)
P-binding region responsible for LCV localization [95]. Notably, PI(3)P bind-
ing enhances SetA’s glucosyltransferase activity [96]. In vitro SetA has multiple 
substrates including actin, vimentin, and the chaperonin CCT5 [96], although it is 
unclear if these substrates are modified during infection.
The cohort of T4SS substrates is not conserved across all L. pneumophila 
strains. Strains harbor variations in their combinations of effectors that have been 
presumably acquired during the course of coevolution with a variety of protozoan 
hosts [97]. Despite these variations, PIP binding is emerging as a common feature 
among effectors of L. pneumophila strains. The L. pneumophila Paris strain encodes 
the glucosyltransferase LtpM that resembles the Philadelphia strain effector, SetA, 
in domain structure and the ability to cause a growth defect in yeast [96, 98]. Unlike 
SetA which uses a typical DxD motif for catalysis, LtpM harbors a noncanonical 
DxN motif. The glucosyltransferase activity LtpM is also stimulated by PI(3)P, 
indicating multiple effectors have evolved to exploit PI(3)P for purposes other than 
directing proper localization.
7. Eukaryotic and bacterial phosphoinositide-binding domains
In eukaryotes, proteins bind PIPs via domains that are highly conserved. 
Protein-lipid binding typically occurs through electrostatic interactions between 
positively charged amino acid residues and the negative phosphate(s) on the 
myo-inositol ring. These protein domains vary in their binding affinity and speci-
ficity for the seven PIP species [99]. The well-characterized pleckstrin homology 
(PH) domain is the eleventh most common domain in humans, found in 275 
 proteins [100]. Proteins harboring the PH domain are recruited to membranes 
through interactions with either PI(3,4)P2, PI(4,5)P2, or PI(3,4,5)P3. The FYVE 
domain confers high specificity for PI(3)P and is present in many proteins that 
localize to endosomes [101, 102]. The phox domain (PX) is commonly found in 
sorting nexins and preferentially binds PI(3)P and in some cases PI(3,4)P2 [103]. 
Intriguingly, bacterial proteins that specifically bind host PIPs do not use eukary-
otic-like domains.
Bacteria can acquire protein domains by horizontal gene transfer from the 
hosts they infect [97]. A number of L. pneumophila effectors harbor eukaryotic-
like domains such as ankyrin repeats, U-Box, F-box, and Sel1 repeats [9]. 
Interestingly, prokaryotic PIP-binding domains were not derived from their 
eukaryotic hosts. Global bioinformatic analysis of 38 Legionella genomes revealed 
a conserved PI(4)P-binding domain found in 36 putative effectors, while a 
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domain termed LED006 is found in 136 effectors from 30 species [8]. The PI(4)
P-binding domain was experimentally validated to be functional in SidM, 
Lpg1101, and Lpg2603 [73, 77].
A recent study identified three conserved PI(3)P-binding domains present in 
14 Legionella effectors across 41 Legionella species: LED006, LED027, and LED025 
[66]. All three domains rely on positively charged or aromatic residues confined 
to the C-terminus and are accompanied by an adjacent enzymatic or protein-
binding domain. LED006 displayed the weakest affinity for PI(3)P yet is the most 
conserved, found in eight L. pneumophila effectors: CegC2, LegK1, Ceg22, LegC5, 
Lem9, LegC6, LepB, and Lpg2327. Only LegK1, LegC5, and LepB have been stud-
ied and shown to possess catalytic activity. While the C-terminal region of these 
proteins is conserved, the catalytic activity harbored by their N-terminal region 
varies. LegK1 is a serine/threonine kinase that targets the NF-κB pathway, LegC5 is 
a glucosyltransferase that modifies eEF1A, and LepB has dual PI 4-kinase activity 
and a Rab GAP domain. LED027 binds PI(3)P with high affinity and is found in 
RavZ, Lpg1121 (Ceg19), and Lpg1961, although Lpg1961 did not display lipid-bind-
ing activity when tested in vitro. LED035 is present in RavB, Lem21, and MavH, 
although none have been functionally characterized.
Biochemical analysis of a Vibrio parahaemolyticus effector revealed a conserved 
type III secreted bacterial phosphoinositide-binding domain (BPD) domain that 
mediates membrane localization in eukaryotic cells. The BPD domain is the first 
instance of a domain found in both plant and animal pathogens yet shares no 
homology to eukaryotes suggesting this domain is the result of convergent evolu-
tion [104]. Despite the recent discoveries of novel PIP-binding domains, the PI(3)
P-binding regions in effectors SetA, RavD, LotA, and AnkX have not been linked 
to any conserved domains. We could speculate that perhaps this is because phos-
phoinositide binding is mediated by small, variable motifs or that lipid-binding 
domains may be quite diverse, as is the case for eukaryotic proteins. A clear perspec-
tive on this issue requires further identification, domain mapping, and computa-
tional analysis of known and novel phosphoinositide-binding effectors. Therefore, 
there is much to be learned about the molecular details underlying interactions 
between bacterial proteins and host phosphoinositides.
8. Conclusions and perspectives
What enables L. pneumophila effectors to target multiple membrane trafficking 
pathways stems in part from their modular structures consisting of various com-
binations of protein domains. Many of the PIP binding effectors are characterized 
by the presence of a C-terminal PIP-binding region and an N-terminal region that 
harbors enzymatic activity or interacts with host proteins.
The presence of PI(3)P on phagosomal membranes serves as a signpost for the 
recruitment of endocytic proteins that promote fusion with subsequent endocytic 
compartments and ultimately the lysosome. PI(3)P is therefore an attractive 
target for intracellular pathogens to eliminate entry into the phagosomal matura-
tion pathway. It is well-established that after phagocytosis, PI(3)P on the nascent 
phagosome is rapidly depleted in conjunction with PI(4)P acquisition [12, 42]. 
Multiple studies have supported that this lipid rearrangement is accomplished 
through the actions of PIP-modifying effectors and effectors that promote the 
recruitment and fusion of PI(4)P-rich compartments with the LCV (reviewed in 
[105]). The recent evidence demonstrated that this lipid can also be removed from 
on or around the LCV in the form of PI(3)P-positive vesicles that are shed from 
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the LCV. This would indicate that somehow microdomains of PI(3)P within mem-
branes are being recognized, sequestered, and sorted into vesicles for removal or 
that perhaps PI(3)P-positive vesicles do not stably interact with the LCV. How the 
LCV can distinguish the simultaneous shedding of PI(3)P-compartments with the 
fusion of PI(4)P-compartments has yet to be determined. We can speculate that 
L. pneumophila has evolved cohorts of effectors that can independently regulate 
the acceptance of PI(4)P-rich membrane or the egress of PI(3)P-rich membrane 
from the LCV.
PI(3)P is completely lost from the LCV membrane after 2 hours; however, it 
is unclear why there is a strong presence of PI(3)P-binding effectors that are on 
the LCV membrane after this time point (LpnE, SetA, LotA, RidL, LtpM, LtpD, 
RavD). At later stages of infection, an accumulation of stagnant PI(3)P-positive 
vesicles can be seen surrounding the LCV. It is possible that effectors anchored to 
the LCV could be interacting with these vesicles by recognizing multiple membrane 
compartments. Most LCV localization studies are assessed using light micros-
copy, in which the resolution may not be high enough to visualize smaller distinct 
structures around the LCV. Light microscopy showed RavD is present on the LCV 
membrane; however higher-resolution imaging techniques like structured illumina-
tion and transmission electron microscopy revealed RavD is also present on a subset 
of unidentified vesicles adjacent to the LCV. It is most likely these vesicles are PI(3)
P-rich, as RavD does not localize to PI(4)P-positive compartments. Moreover, RavD 
does not rely on PI(3)P binding to anchor to the LCV, supporting that effectors may 
exhibit dual localization patterns and that RavD may interact with the LCV and 
vesicles through different domains.
L. pneumophila has developed intricate strategies to facilitate intracellular 
growth by circumventing essential host cellular processes. The arsenal of effec-
tors secreted by the type IV secretion system has evolved to target specific 
eukaryotic components such as proteins and lipids. Localization to the correct 
compartments within this host cell is imperative for protein function. A number 
of Legionella effectors rely on phosphoinositides to confer this directionality dur-
ing infection. Not only are phosphoinositides needed to govern organelle identity, 
but they also dictate the path the phagosome embarks on once engulfed into 
the host cell. Thus, some effectors are ingeniously equipped to directly modify 
the lipid content on the phagosome membrane to avoid being routed toward 
degradation. Only a small percentage of effectors have been reported to interact 
with or modify phosphoinositides. Future studies that continue to expand on the 
repertoire of PIP-binding effectors will undoubtedly enhance our understanding 
of how intracellular pathogens survive within membrane-bound compartments 
within eukaryotic hosts.
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